MRP 655.31/- UNIT

Composition

Travoprost IP 0.004% w/v + Benzalkonium Chloride Solution IP 0.02% v/v (as preservative) + Sterile Aqueous Base q.s.

Doses

As Directed by Physician

Description

Travoprost Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple. 

Formulation

Liquied